Literature DB >> 22801751

Liver fibrosis: how many samples in transjugular liver biopsy are sufficient? Histological vs. clinical value.

Malgorzata Wolska-Krawczyk1, Marcin Krawczyk, Marcus Katoh, Frank Grünhage, Kai Schmitt, Rainer M Bohle, Frank Lammert, Arno Buecker.   

Abstract

PURPOSE: Liver biopsy (LB) is a diagnostic procedure to obtain histological diagnosis, grading and staging in individuals with liver diseases. Most commonly LB is performed percutaneously. However, transjugular liver biopsy (TJLB) is considered as an alternative. The aim of this prospective study was to evaluate the diagnostic accuracy of TJLB.
METHODS: TJLB with a semi-automatic Tru-Cut System (18G) was performed in 39 patients with various liver diseases (21 females and 18 males; age range 11-77 years). The number of complete portal tracts (CPTs), lengths and numbers of acquired cores, number of performed cutting steps (passes), and the possibility to obtain histological diagnosis were analyzed.
RESULTS: There were no procedure-related complications, and in total 45 procedures were performed. Diagnosis could be established in 88.8 % of all samples, in five cases histology yielded no diagnosis due to an inadequate number of CPTs or sample fragmentation. In average, 4 passes were performed and 4 (range 1-7) cores were obtained. Median core length was 1.1 cm (range 0.4-1.9 cm), median number of CPTs was 7 (range 0-20). Liver fibrosis in general led to a decreased number of CPTs (p < 0.05).
CONCLUSIONS: TJLB is a safe procedure allowing histological diagnosis of liver diseases. In our cohort, performing 4 cutting procedures during TJLB resulted in a sufficiently high specimen quality, particularly in individuals with liver cirrhosis.

Entities:  

Mesh:

Year:  2013        PMID: 22801751     DOI: 10.1007/s00261-012-9939-6

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  4 in total

1.  Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.

Authors:  Marcin Krawczyk; Simone Zimmermann; Georg Hess; Robert Holz; Marc Dauer; Jochen Raedle; Frank Lammert; Frank Grünhage
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

2.  Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases.

Authors:  Makoto Iijima; Takahiro Arisaka; Akira Yamamiya; Keiichi Tominaga; Kazunori Nagashima; Akira Kanamori; Satoshi Masuyama; Yuichi Majima; Kenichi Goda; Kazuyuki Ishida; Atsushi Irisawa
Journal:  Diagnostics (Basel)       Date:  2021-01-16

3.  Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction.

Authors:  Toru Ishikawa; Erina Kodama; Takamasa Kobayashi; Motoi Azumi; Yujiro Nozawa; Akito Iwanaga; Tomoe Sano; Terasu Honma
Journal:  Cureus       Date:  2021-11-14

4.  Percutaneous ultrasound-guided plugged liver biopsy - a single-centre experience.

Authors:  Soumil Singhal; Pradeep M D; Srikar Inuganti; Sandeep Botcha; Deepashree Thiruchunapalli Deepashree; Mangerira C Uthappa
Journal:  Pol J Radiol       Date:  2021-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.